Movetis's constipation drug Resolor debuts in Germany
This article was originally published in Scrip
Executive Summary
Movetis has launched its lead product Resolor (prucalopride) film-coated tablets in Germany – its first market – for the symptomatic treatment of chronic constipation in women for whom laxatives fail to work. The product was approved in the EU in October.